2017
DOI: 10.1016/j.ejrad.2017.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation of brain tumor-related edema based on 3D T1rho imaging

Abstract: Background and purpose Cerebral edema associated with brain tumors is an important source of morbidity. Its type depends largely on the capillary ultra-structures of the histopathologic subtype of underlying brain tumor. The purpose of our study was to differentiate vasogenic edema associated with brain metastases and infiltrative edema related to diffuse gliomas using quantitative 3D T1 rho (T1ρ) imaging. Materials and methods Preoperative MR examination including whole brain 3D T1ρ imaging was performed in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
16
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 30 publications
(36 reference statements)
0
16
0
Order By: Relevance
“…T 1ρ relaxation imaging is a quantitative imaging technique that has been used to assess cartilage integrity, liver fibrosis, tumors, cardiac infarction, and Alzheimer's disease . T 1ρ relaxation has also been shown to correlate with large molecules that tumble at low frequencies, including proteoglycans in ex vivo bovine and human cartilage experiments, demonstrating a decrease in T 1ρ relaxation time as the proteoglycan concentration decreases.…”
Section: Introductionmentioning
confidence: 99%
“…T 1ρ relaxation imaging is a quantitative imaging technique that has been used to assess cartilage integrity, liver fibrosis, tumors, cardiac infarction, and Alzheimer's disease . T 1ρ relaxation has also been shown to correlate with large molecules that tumble at low frequencies, including proteoglycans in ex vivo bovine and human cartilage experiments, demonstrating a decrease in T 1ρ relaxation time as the proteoglycan concentration decreases.…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7][8] Therefore, brain T 1ρ mapping may provide early imaging biomarkers for various pathological processes, including Parkinson's disease, dementia, Alzheimer's disease, stroke, neoplasm, and multiple sclerosis. [9][10][11][12][13][14][15][16][17][18][19][20][21] T 1ρ relaxation is traditionally described in many in vivo tissues with a monoexponential decay model. 11,[22][23][24][25] However, recent studies have shown that T 1ρ relaxation has multiexponential components, especially biexponential components.…”
Section: Introductionmentioning
confidence: 99%
“…As a result, T 1 ρ imaging provides additional information about macromolecular changes compared with conventional T 1 and T 2 MRI . Therefore, brain T 1 ρ mapping may provide early imaging biomarkers for various pathological processes, including Parkinson's disease, dementia, Alzheimer's disease, stroke, neoplasm, and multiple sclerosis …”
Section: Introductionmentioning
confidence: 99%
“…To date, many studies have explored the distinction between GBM and LGG on multiple levels, including mutation, methylation, gene expression, imaging, clinical treatment and so on. Many positron emission tomography (PET)/single‐photon emission computed tomography (SPECT)/three‐dimensional (3D) T1rho imaging studies on brain tumors have explored the differential diagnosis between GBM and LGG . Previous studies have reported that the somatic intronic microsatellite loci differentiate between GBMs and LGGs .…”
Section: Introductionmentioning
confidence: 99%
“…Many positron emission tomography (PET)/single-photon emission computed tomography (SPECT)/three-dimensional (3D) T1rho imaging studies on brain tumors have explored the differential diagnosis between GBM and LGG. 7,8 Previous studies have reported that the somatic intronic microsatellite loci differentiate between GBMs and LGGs. 9 Reon et al 10 suggested that there were some differential long noncoding RNAs (lncRNAs) between GBMs and LGGs.…”
Section: Introductionmentioning
confidence: 99%